Two new studies find a possible target for treating a broad range of heart dysfunction.
January 27, 2021
A multidisciplinary team is developing job assistance software for those with neurodevelopmental disabilities, thanks to a $2.3 million NSF grant.
January 19, 2021
In the absence of “patient zero,” Temple researchers have found the first coronavirus genome.
November 4, 2020
A $3.8 million grant will support an investigation of risk factors for Alzheimer’s disease by Temple researchers.
A College of Public Health study is exploring COVID-19’s impact on individuals with substance use disorder.
Temple’s Department of Physics joins a national effort to develop revolutionary quantum computers.
A $5 million gift by Andréa and Ken Frazier will support the program.
A Katz School alumnus has established a new lymphatics research center with a gift of $5 million.
Researchers at Temple University Hospital are testing a new immunotherapy for COVID-19 patients.
A CST researcher is carefully watching for evidence that the COVID-19 virus is mutating or adapting.
The international survey-based research delves deeper into taste- and smell-related symptoms.
Temple’s Gerard Criner is the principal investigator at Temple University Hospital for a new clinical trial evaluating a potential treatment for COVID-19 patients.
More than 1 million participants worldwide are running computer simulations at home to find potential drugs to counteract the coronavirus.